Lymphoma, Small Lymphocytic Clinical Trials

19 clinical trials for Lymphoma, Small Lymphocytic across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010). — RECRUITING · PHASE3
• A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — RECRUITING · PHASE4
• Long-term Follow-up Study of Patients Receiving CAR-T Cells — RECRUITING
• Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) — ACTIVE_NOT_RECRUITING · PHASE1
• A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma — COMPLETED · PHASE2
• Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas — COMPLETED · PHASE2
• Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY) — TERMINATED · PHASE1
• Intermittent Fasting and CLL/SLL — COMPLETED · PHASE1
• Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL — COMPLETED · PHASE1
• Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL — TERMINATED
• Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL) — TERMINATED · PHASE2
• Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers — OTHER · PHASE3
• Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — WITHDRAWN · PHASE1
• Tandem Auto-Allo Transplant for Lymphoma — COMPLETED · PHASE2
• Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — COMPLETED · PHASE2
• Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma — COMPLETED · PHASE1
• A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL) — TERMINATED · PHASE1
• EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — TERMINATED · PHASE2
• A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia — TERMINATED · PHASE2

Refine this search